Strathfield, Australia

Alex Inkeun Leesong

This inventor holds 1 USPTO granted patent. Top assignee: Pangen Biotech Inc.. Active years: 2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alex Inkeun Leesong. Retrieved from https://idiyas.com/inventor/alex-inkeun-leesong

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Alex Inkeun Leesong: Innovator in Mammalian Expression Vectors

Introduction

Alex Inkeun Leesong is a notable inventor based in Strathfield, Australia. He has made significant contributions to the field of biotechnology, particularly in the development of expression vectors for animal cells. His work focuses on enhancing the efficiency of recombinant protein expression.

Latest Patents

Alex holds a patent for an expression vector that incorporates the nuclear matrix attachment region of human interferon beta. This invention, which includes vectors pPGM-1, pPGM-2, and pPGM-3, allows for position-independent expression of introduced foreign genes. As a result, it increases the frequency of colonies that effectively express recombinant proteins.

Career Highlights

Alex is currently associated with Pangen Biotech Inc., where he continues to advance his research and development efforts. His innovative work has positioned him as a key figure in the biotechnology sector.

Collaborations

He collaborates with talented individuals such as Jeong Do Kim and Hye-Yeon Hwang, contributing to a dynamic research environment.

Conclusion

Alex Inkeun Leesong's contributions to biotechnology through his patented inventions demonstrate his commitment to advancing the field. His work not only enhances scientific understanding but also paves the way for future innovations in protein expression.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…